DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Apriso (Mesalamine) - Current Clinical Trials

 
 



Apriso Related Clinical Trials

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis [Completed]

Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Completed]

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Recruiting]

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine [Completed]

Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. [Completed]

Canadian Active & Maintenance Modified Pentasa Study [Completed]

Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) [Completed]

Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Completed]

Correlation of Mesalamine Pharmacokinetics With Local Availability [Active, not recruiting]

Cimzia Versus Mesalamine for Crohn's Recurrence [Recruiting]

Predicting Response to Standardized Pediatric Colitis Therapy [Active, not recruiting]

Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon [Completed]

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Completed]

Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) [Completed]

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers [Completed]

Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study [Completed]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Terminated]

Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) [Completed]

Mesalazine Effects in Sporadic Colorectal Adenoma Patients [Recruiting]

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [Terminated]

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis [Recruiting]

Mesalamine in Environmental Enteropathy [Completed]

Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome [Recruiting]

Mesalazine Treatment in IBS (The MIBS Study) [Recruiting]

The Colitis Once Daily Asacol Study [Completed]

Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis [Recruiting]

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Completed]

Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine [Completed]

A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome [Completed]

Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease [Completed]

Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine [Completed]

Sulfamethoxazole Drug Interaction Study With MMX� Mesalazine/Mesalamine [Completed]

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase [Recruiting]

A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. [Terminated]

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) [Not yet recruiting]

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) [Not yet recruiting]

Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis [Completed]

Mesalamine 4 gm/60 mL Rectal Enema [Completed]

Amoxicillin Drug Interaction Study With MMX� Mesalazine/Mesalamine [Completed]

Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea [Completed]

Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Completed]

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) [Completed]

Asacol Acute Diverticulitis(DIVA)Study [Completed]

Mesalamine to Reduce T Cell Activation in HIV Infection [Completed]

Asacol Dosing Study for Active Ulcerative Colitis [Completed]

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis [Recruiting]

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis [Completed]

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) [Not yet recruiting]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Completed]

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Completed]

A Study With Pentasa in Patients With Active Crohn's Disease [Terminated]

Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) [Recruiting]

Targeting Oxidative Stress in Chronic Beryllium Disease [Completed]

Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis [Completed]

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Completed]

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Completed]

PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers [Completed]

A BE Study Comparing Mesalamine 400 mg to ASACOL� 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis [Completed]

Clinical Trial With Mesalamine 1g Suppositories [Terminated]

Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis [Completed]

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis [Completed]

Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis [Recruiting]

Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease [Completed]

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) [Completed]

Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations [Completed]

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Terminated]

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission [Completed]

Mesalazine (PENTASA®) in Ulcerative Colitis [Completed]

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [Completed]

Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission [Completed]

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares [Completed]

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis [Recruiting]

Evaluation of the Metabolome in Diverticular Disease [Recruiting]

Taste Assessment Study of SHP429 in Healthy Adult Subjects [Completed]

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA [Completed]

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis [Terminated]

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) [Active, not recruiting]

Dose Escalation and Remission (DEAR) [Completed]

TP05 for the Treatment of Mild to Moderate Active UC [Active, not recruiting]

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment [Recruiting]

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553 AM2) [Terminated]

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [Completed]

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease [Completed]

Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers [Completed]

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Terminated]

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) [Completed]

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis [Completed]

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis [Completed]

Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease [Recruiting]

A Double Blind Study for the Treatment of Acute Ulcerative Colitis [Completed]

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis [Terminated]

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015